Trademark: 76265109
Status Date
Friday, July 26, 2013
Registration Number
3187710
Registration Date
Tuesday, December 19, 2006
Filing Date
Friday, May 25, 2001
Published for Opposition
Tuesday, September 24, 2002
Cancellation Date
Friday, July 26, 2013
1 Biochemicals, namely, monoclonal antibodies and fragments thereof for research and development, and manufacturing pharmaceuticals; and cell lines for use in the manufacture of pharmaceuticals
5 Biochemicals, namely, monoclonal antibodies and fragments thereof for clinical, diagnostic and therapeutic use for the treatment of cancer, infectious diseases, inflammatory diseases, and genetic diseases; and cell lines for clinical, diagnostic and therapeutic use for the treatment of cancer, infectious diseases, inflammatory diseases, and genetic diseases
Jul 26, 2013
Cancelled Sec. 8 (6-Yr)
Dec 19, 2006
Registered-Principal Register
Nov 14, 2006
Law Office Registration Review Completed
Nov 3, 2006
Assigned To Lie
Oct 30, 2006
Allowed Principal Register - Sou Accepted
Oct 20, 2006
Statement Of Use Processing Complete
Sep 18, 2006
Use Amendment Filed
Sep 18, 2006
Paper Received
May 31, 2006
Extension 1 Granted
May 18, 2006
Extension 1 Filed
May 18, 2006
Teas Extension Received
Nov 22, 2005
Noa Mailed - Sou Required From Applicant
Aug 29, 2005
Opposition Terminated No. 999999
Aug 29, 2005
Opposition Dismissed No. 999999
Jan 31, 2003
Opposition Instituted No. 999999
Sep 24, 2002
Published For Opposition
Sep 4, 2002
Notice Of Publication
Apr 8, 2002
Approved For Pub - Principal Register
Feb 28, 2002
Correspondence Received In Law Office
Aug 29, 2001
Non-Final Action Mailed
Aug 16, 2001
Assigned To Examiner
Aug 14, 2001
Assigned To Examiner
Aug 9, 2001
Assigned To Examiner
Trademark Alertz updated from USPTO on 2030-01-24
